Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation
2005
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Mitral Valve Prolapse With Mid-Late Systolic Mitral Regurgitation
2012
Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation
2018
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Homocysteine and vascular disease
1999 Standout
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Determinants of echocardiographic left atrial volume: implications for normalcy
2011
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Impaired Nitric Oxide-Mediated Flow-Induced Coronary Dilation in Hyperhomocysteinemia
2002
Left atrial size and risk for all-cause mortality and ischemic stroke
2011
Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?
2011
n–3 Fatty Acids in Cardiovascular Disease
2011
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
2010
Hallmarks of aging: An expanding universe
2023 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
2001
Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function
2005
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Heat Stroke
2002 Standout
Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study
2016
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation
2012
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia
2000
Fish Intake, Contaminants, and Human Health
2006 Standout
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
2002
Clinical Outcome of Isolated Tricuspid Regurgitation
2014
Pre-eclampsia
2010 Standout
Burden of valvular heart diseases: a population-based study
2006 Standout
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension
2017
Effects of Folate Treatment and Homocysteine Lowering on Resistance Vessel Reactivity in Atherosclerotic Subjects
2002
Hyperhomocysteinemia, Pregnancy Complications, and the Timing of Investigation
2004
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Homocysteine and cardiovascular disease:
2002
Cells of primarily extravalvular origin in degenerative aortic valves and bioprostheses
2005
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Impact of Left Atrial Volume on Clinical Outcome in Organic Mitral Regurgitation
2010
Atherosclerosis
2000 StandoutNature
Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis
2007
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Homocysteine and atherosclerosis
1999
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Biomarkers in Heart Failure
2008 Standout
Incidence and Progression of Aortic Valve Calcium in the Multi-Ethnic Study of Atherosclerosis (MESA)
2010
Adherence to a Mediterranean Diet and Survival in a Greek Population
2003 Standout
Longchain n−3 polyunsaturated fatty acids and blood vessel function
2001
ADMA and oxidative stress
2003
Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy
2000
Impact of Obstructive Sleep Apnea on Left Ventricular Mass and Diastolic Function
2001
Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis
2004
Flail mitral and tricuspid valves due to myxomatous disease
2006
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Quantitative assessment of effective regurgitant orifice: impact on risk stratification, and cut-off for severe and torrential tricuspid regurgitation grade
2019
Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes
2000
Long-Term Prognosis of Isolated Significant Tricuspid Regurgitation
2010
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Left Atrial Size Is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets
2011
Effects of Methionine-Induced Hyperhomocysteinemia on Endothelium-Dependent Vasodilation and Oxidative Status in Healthy Adults
2000
Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation
2010
Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness
2001
Clinical Context and Mechanism of Functional Tricuspid Regurgitation in Patients With and Without Pulmonary Hypertension
2012
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Short‐term interleukin‐37 treatment improves vascular endothelial function, endurance exercise capacity, and whole‐body glucose metabolism in old mice
2019
Potentiation of Baroreceptor Reflex Response by Heat Shock Protein 70 in Nucleus Tractus Solitarii Confers Cardiovascular Protection During Heatstroke
2001
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction
2019
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
Spectrum of Calcific Aortic Valve Disease
2005
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Usefulness of Left Atrial Volume Versus Diameter to Assess Thromboembolic Risk in Mitral Stenosis
2010
Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up
2005
Xanthine Oxidase–Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in Hyperhomocysteinemia
2002
Role of Oxidant Stress in Endothelial Dysfunction Produced by Experimental Hyperhomocyst(e)inemia in Humans
1999
The diagnosis and management of anaphylaxis: An updated practice parameter
2005
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Vascular Calcification
2006 Standout
Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation
2004
ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.
1998
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography
2004
Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study
1999
Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice
2001
Endothelial Function and Dysfunction
2007 Standout
Works of Michael Bellamy being referenced
Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community
2002
Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets
2004
Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia
2000
Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study
2007
Putative mechanisms for vascular damage by homocysteine
1997
Endothelial Function in Marfan Syndrome
1999
Homocysteine-Induced Inhibition of Endothelium-Dependent Relaxation in Rabbit Aorta
2000
Hyperhomocysteinemia After an Oral Methionine Load Acutely Impairs Endothelial Function in Healthy Adults
1998
Unexplained loss of consciousness: Systemic mastocytosis
2000